BrainsWay Ltd. (TLV:BWAY)
2,695.00
-51.00 (-1.86%)
Sep 18, 2025, 5:28 PM IDT
BrainsWay Market Cap
BrainsWay has a market cap or net worth of 1.04 billion as of September 18, 2025. Its market cap has increased by 121.35% in one year.
Market Cap
1.04B
Enterprise Value
796.71M
Revenue
155.27M
Ranking
n/a
PE Ratio
73.81
Stock Price
2,695.00
Market Cap Chart
Since September 24, 2007, BrainsWay's market cap has increased from 101.45M to 1.04B, an increase of 924.00%. That is a compound annual growth rate of 13.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 18, 2025 | 1.02B | 55.66% |
Dec 31, 2024 | 656.96M | 72.83% |
Dec 31, 2023 | 380.12M | 223.68% |
Dec 29, 2022 | 117.44M | -70.48% |
Dec 30, 2021 | 397.80M | 56.55% |
Dec 31, 2020 | 254.10M | -32.02% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 71.58B |
Danel (Adir Yeoshua) | 2.77B |
Kamada | 1.35B |
SofWave Medical | 914.79M |
Bait Bakfar | 909.14M |
Ilex Medical | 717.27M |
Novolog (Pharm-Up 1966) | 660.56M |
Bonus BioGroup | 254.61M |